ELECLA: Analysis of effectiveness of neoadjuvant chemotherapy in the treatment of locally advanced colon cancer.

Trial Overview

Acronym ELECLA
Number EudraCT number: 2016-002970-10. AEMPS number: AEMPS: 16-0553.
Protocol Link https://reec.aemps.es/reec/public/detail.html
Public Trial Registry Link https://reec.aemps.es/reec/public/detail.html
Status Open/recruiting
Category Colorectal Cancer - Colonic Specific
Treatment Course Neoadjuvant

Trial Description

Current standard therapy for locally advanced colon cancer (LACC) is based on surgery followed by adjuvant chemotherapy. It is proposed a clinical trial to determine, on one hand, if neoadjuvant therapy in LACC patients achieves clinical and pathologic tumour response, and on the other hand, to assess if this therapeutic sequence translates into a survival benefit, without increasing morbi-mortality. Patients will be included according to homogeneous inclusion criteria, and will be treated homog

Chief Investigator

M.D. Ph.D Jorge Arredondo Chaves
M.D. Ph.D.
Profile Link

Lead Centre

Hospital de León
Altos de Navas
León
24009
Spain
Website

Collaboration and Funding

Collaborative Sites

Additional Information

Full Research Summary
Affiliate Societies